ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-64642

NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client

Published Dec 2, 2025 · catalog updated Dec 2, 2025 · Mirion Medical EC2 Software NMIS BioDose

Last checked Oct 28, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2025-64642. EPSS is 0.12%. Act only if a listed version of Mirion Medical EC2 Software NMIS BioDose is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.

Same product and reporting

Severity
High7.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.12%
Remediation
Version ranges on file
Affected products
vendor Mirion Medical EC2 Software NMIS BioDose 0 <23.0

NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Mirion Medical EC2 Software NMIS BioDose 0 <23.00 <23.0

How to fix CVE-2025-64642

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-64642. EPSS is 0.12%. Act only if a listed version of Mirion Medical EC2 Software NMIS BioDose is installed.

Which versions are affected?

Compare what you have installed with Mirion Medical EC2 Software NMIS BioDose 0 <23.0 0 <23.0. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.12%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Dec 2, 2025 · EUVD

    Detected

    NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.

  2. Dec 2, 2025 · EUVD

    Updated

    NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.

Sources

  • CVE.orgVulnerability recordCVE-2025-64642

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-64642

    30-day exploitation probability 0.12%

    first.org
  • EUVDVulnerability recordEUVD-2025-200324

    NMIS/BioDose V22.02 and previous versions' installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 28, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • FIRST EPSSOct 28, 2026
  • CVE.orgOct 28, 2026
  • EUVDOct 27, 2026